Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with Updated Commentary of the Cologne Consensus Conference 2011. (Q37973537)

26 August 2017

title

Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with Updated Commentary of the Cologne Consensus Conference 2011. (English)

1 reference

26 August 2017

main subject

arterial hypertension

0 references

pulmonary hypertension

1 reference

10

1 reference

26 August 2017

13

Gabriela Riemekasten

1 reference

26 August 2017

5

Michael Dandel

1 reference

26 August 2017

9

Gabor Kovacs

1 reference

26 August 2017

Ekkehard Grünig

1

1 reference

26 August 2017

Andreas Barner

2

1 reference

26 August 2017

Michael Bell

3

1 reference

26 August 2017

Martin Claussen

4

1 reference

26 August 2017

Daniel Dumitrescu

6

1 reference

26 August 2017

Matthias Gorenflo

7

1 reference

26 August 2017

Stephan Holt

8

1 reference

26 August 2017

Joachim F Meyer

11

1 reference

26 August 2017

Stefan Pabst

12

1 reference

26 August 2017

Joachim Saur

14

1 reference

26 August 2017

Martin Schwaiblmair

15

1 reference

26 August 2017

Cathérine Seck

16

1 reference

26 August 2017

Lutz Sinn

17

1 reference

26 August 2017

Stephan Sorichter

18

1 reference

26 August 2017

Jörg Winkler

19

1 reference

26 August 2017

Hanno H Leuchte

20

1 reference

26 August 2017

publication date

1 December 2011

1 reference

International Journal of Cardiology

26 August 2017

published in

1 reference

26 August 2017

volume

154 Suppl 1

1 reference

26 August 2017

page(s)

S3-12

1 reference

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Guidelines for the diagnosis and treatment of pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Diagnostik und Therapie der pulmonalen Hypertonie: Europäische Leitlinien 2009

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Primary pulmonary hypertension. A national prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Diagnosis and assessment of pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Estimating pulmonary artery pressures by echocardiography in patients with emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology,

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

A noninvasive algorithm to exclude pre-capillary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Pulmonary Hypertension:CT of the Chest in Pulmonary Venoocclusive Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Chronic thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Chronic thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Magnetic Resonance–Derived 3-Dimensional Blood Flow Patterns in the Main Pulmonary Artery as a Marker of Pulmonary Hypertension and a Measure of Elevated Mean Pulmonary Arterial Pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Antinuclear antibodies in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Brain natriuretic peptide is a prognostic parameter in chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

1 reference

7 January 2021

Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

ATS/ACCP statement on cardiopulmonary exercise testing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Recommendations on the use of exercise testing in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Exercise-induced pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Exercise pathophysiology in patients with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Exercise testing to estimate survival in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

1 reference

7 January 2021

Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Exercise stress echocardiography for the study of the pulmonary circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Abnormal Pulmonary Artery Pressure Response in Asymptomatic Carriers of Primary Pulmonary Hypertension Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Abnormal pulmonary vascular responses in patients registered with a systemic autoimmunity database: Pulmonary Hypertension Assessment and Screening Evaluation using stress echocardiography (PHASE-I)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Determinants of exercise-induced pulmonary hypertension in patients with normal left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Clinical outcomes of exercise-induced pulmonary hypertension in subjects with preserved left ventricular ejection fraction: implication of an increase in left ventricular filling pressure during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Hyperuricemia in severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Pulmonary Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Tricuspid annular displacement predicts survival in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Doppler echocardiographic index for assessment of global right ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

Right ventricular function in infants, children and adolescents: reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970488-0

7 January 2021

10.1016/S0167-5273(11)70488-0

Identifiers

DOI

1 reference

26 August 2017

1 reference